Principal Financial Group’s Lyell Immunopharma LYEL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10,997
| Closed | -$5.92K | – | 2281 |
|
|
2025
Q1 | $5.92K | Hold |
10,997
| – | – | ﹤0.01% | 2166 |
|
|
2024
Q4 | $7.04K | Sell |
10,997
-216
| -2% | -$138 | ﹤0.01% | 2206 |
|
|
2024
Q3 | $15.5K | Sell |
11,213
-15,297
| -58% | -$21.1K | ﹤0.01% | 2214 |
|
|
2024
Q2 | $38.4K | Sell |
26,510
-31,744
| -54% | -$46K | ﹤0.01% | 2304 |
|
|
2024
Q1 | $130K | Sell |
58,254
-4,661
| -7% | -$10.4K | ﹤0.01% | 2245 |
|
|
2023
Q4 | $122K | Sell |
62,915
-5,165
| -8% | -$10K | ﹤0.01% | 2239 |
|
|
2023
Q3 | $100K | Buy |
68,080
+7,915
| +13% | +$11.6K | ﹤0.01% | 2282 |
|
|
2023
Q2 | $191K | Buy |
60,165
+5,540
| +10% | +$17.6K | ﹤0.01% | 2192 |
|
|
2023
Q1 | $129K | Buy |
54,625
+5,767
| +12% | +$13.6K | ﹤0.01% | 2258 |
|
|
2022
Q4 | $170K | Buy |
48,858
+3,166
| +7% | +$11K | ﹤0.01% | 2224 |
|
|
2022
Q3 | $335K | Buy |
45,692
+9,660
| +27% | +$70.8K | ﹤0.01% | 2052 |
|
|
2022
Q2 | $235K | Sell |
36,032
-11,687
| -24% | -$76.2K | ﹤0.01% | 2252 |
|
|
2022
Q1 | $241K | Buy |
47,719
+19,068
| +67% | +$96.3K | ﹤0.01% | 2294 |
|
|
2021
Q4 | $222K | Buy |
+28,651
| New | +$222K | ﹤0.01% | 2331 |
|